BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 1334552)

  • 1. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
    Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
    Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
    Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally restricted deltorphin analogues.
    Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
    J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
    Weltrowska G; Nguyen TM; Chung NN; Wilkes BC; Schiller PW
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5082-5. PubMed ID: 23932788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
    J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
    J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
    J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.
    Schmidt R; Kálmán A; Chung NN; Lemieux C; Horváth C; Schiller PW
    Int J Pept Protein Res; 1995 Jul; 46(1):47-55. PubMed ID: 7558596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactivity of new mu and delta opioid peptides.
    Capasso A
    Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
    J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
    J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC; Schiller PW
    Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity.
    Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
    J Med Chem; 1993 Oct; 36(21):3182-7. PubMed ID: 8230106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
    Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
    J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
    Wilkes BC; Schiller PW
    Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
    Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
    Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.
    Wilkes BC; Nguyen TM; Weltrowska G; Carpenter KA; Lemieux C; Chung NN; Schiller PW
    J Pept Res; 1998 May; 51(5):386-94. PubMed ID: 9606018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.